Revenue | ₹294.97Cr |
Net Profits | ₹-88.70Cr |
Net Profit Margins | -30.07% |
OneSource Specialty Pharma Ltd’s revenue fell -26.12% since last year same period to ₹294.97Cr in the Q3 2025-2026. On a quarterly growth basis, OneSource Specialty Pharma Ltd has generated -22.13% fall in its revenue since last 3-months.
OneSource Specialty Pharma Ltd’s net profit fell -28.83% since last year same period to ₹-88.70Cr in the Q3 2025-2026. On a quarterly growth basis, OneSource Specialty Pharma Ltd has generated -945.57% fall in its net profits since last 3-months.
OneSource Specialty Pharma Ltd’s net profit margin fell -74.39% since last year same period to -30.07% in the Q3 2025-2026. On a quarterly growth basis, OneSource Specialty Pharma Ltd has generated -1185.88% fall in its net profit margins since last 3-months.
The revenue for OneSource Specialty Pharma Ltd in the Q3 results 2025 was ₹294.97Cr.
The net profit for OneSource Specialty Pharma Ltd in the Q3 results 2025 was ₹-88.70Cr.
The net profit margin for OneSource Specialty Pharma Ltd in the Q3 results 2025 was -30.07%.
The revenue for OneSource Specialty Pharma Ltd in the Q3 results 2024 was ₹399.28Cr.
The net profit for OneSource Specialty Pharma Ltd in the Q3 results 2024 was ₹-68.85Cr.
The net profit margin for OneSource Specialty Pharma Ltd in the Q3 results 2024 was -17.24%.